Firefly Neuroscience (AIFF) Net Cash Flow (2010 - 2026)

Firefly Neuroscience has reported Net Cash Flow for 17 years, with the latest figure at $6.1 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 268.16% year-over-year to $6.1 million in Q2 2026; TTM through Jun 2026 was $3.3 million, a 134.61% increase from a year earlier, with the FY2025 full-year figure at $937000.0, up 381.38% from the prior year.
• Net Cash Flow was $6.1 million for Q2 2026 at Firefly Neuroscience, up from $380000.0 in the prior quarter.
• The five-year high for Net Cash Flow was $7.7 million in Q1 2025, with the low at -$3.6 million in Q2 2025.
• Average Net Cash Flow over 5 years is $25121.5, with a median of -$505000.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow plunged 703.77% in 2024, then soared 1631.68% in 2025.
• Over 5 years, Net Cash Flow stood at -$2.5 million in 2022, then jumped by 150.79% to $1.2 million in 2023, then tumbled by 173.04% to -$913000.0 in 2024, then tumbled by 72.84% to -$1.6 million in 2025, then soared by 486.5% to $6.1 million in 2026.
• The last three Net Cash Flow figures came in at $6.1 million (Q2 2026), $380000.0 (Q1 2026), and -$1.6 million (Q4 2025), per Business Quant data.